adc in platinum-resistant ovarian cancer
Published 5 years ago • 576 plays • Length 6:54Download video MP4
Download video MP3
Similar videos
-
14:46
managing platinum-resistant ovarian cancer
-
6:57
bevacizumab in platinum-resistant ovarian cancer
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
2:19
dr. moore on anticipated impact of the mirasol trial in platinum-resistant ovarian cancer
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer
-
1:22
dr. naumann on data with stro-002 in platinum-resistant/refractory ovarian cancer
-
5:25
platinum resistance in ovarian cancer
-
30:19
emerging opportunities in platinum-resistant recurrent ovarian cancer
-
1:19
relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
-
5:40
diagnosis of metastatic platinum-resistant ovarian cancer
-
1:41
dr. konner on preferred platinum doublets in recurrent ovarian cancer
-
7:10
managing platinum-resistance and recurrent disease
-
1:47
mirvetuximab soravtansine remains well tolerated in platinum-resistant ovarian cancer
-
1:27
dr. gilbert on evaluating mirvetuximab soravtansine in platinum-agnostic ovarian cancer
-
6:57
the role of i-o in platinum-resistant recurrent oc
-
8:03
bevacizumab in platinum-sensitive ovarian cancer
-
9:05
case 4: recurrent ovarian cancer, platinum-resistant, brca wt
-
26:58
ask the experts: adcs in ovarian cancer
-
0:59
dr secord on mirvetuximab soravtansine in platinum-sensitive, frα-high ovarian cancer